Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Simard

Showing results (121-130 of 290) with videos related to

Pageof 29
Sort By:
Communications Medicine|April 21, 2026
Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in CanadaNareh Safieh-Garabedian, Antonis C Antoniou, Jennifer Brooks, et al.
Journal of Medical Genetics|August 15, 2006
Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancerJacques Simard, Martine Dumont, Anne-Marie Moisan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutationsSophie M Ginolhac, Sophie Gad, Marilys Corbex, et al.
International Journal of Cancer|July 3, 2019
Evaluation of associations between genetically predicted circulating protein biomarkers and breast cancer riskXiang Shu, Jiandong Bao, Lang Wu, et al.
Journal of the National Cancer Institute|May 31, 2019
Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European DescentYaohua Yang, Lang Wu, Xiao-Ou Shu, et al.
Nature Reviews. Clinical Oncology|July 1, 2020
Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
Nature Reviews. Clinical Oncology|June 20, 2020
Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
Cancers|June 19, 2024
Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and OpportunitiesMeghan J Walker, Kristina M Blackmore, Amy Chang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriersDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 14, 2025
Psychological and emotional impacts of communicating breast cancer risk using multifactorial assessment with polygenic risk score: findings from PERSPECTIVE I&ILaurence Lambert-Côté, Annie Turgeon, Kristina M Blackmore, et al.
Pageof 29

Showing results (121-130 of 290) with videos related to

Sort By:
Pageof 29
Communications Medicine|April 21, 2026
Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in CanadaNareh Safieh-Garabedian, Antonis C Antoniou, Jennifer Brooks, et al.
Journal of Medical Genetics|August 15, 2006
Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancerJacques Simard, Martine Dumont, Anne-Marie Moisan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutationsSophie M Ginolhac, Sophie Gad, Marilys Corbex, et al.
International Journal of Cancer|July 3, 2019
Evaluation of associations between genetically predicted circulating protein biomarkers and breast cancer riskXiang Shu, Jiandong Bao, Lang Wu, et al.
Journal of the National Cancer Institute|May 31, 2019
Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European DescentYaohua Yang, Lang Wu, Xiao-Ou Shu, et al.
Nature Reviews. Clinical Oncology|July 1, 2020
Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
Nature Reviews. Clinical Oncology|June 20, 2020
Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
Cancers|June 19, 2024
Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and OpportunitiesMeghan J Walker, Kristina M Blackmore, Amy Chang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriersDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 14, 2025
Psychological and emotional impacts of communicating breast cancer risk using multifactorial assessment with polygenic risk score: findings from PERSPECTIVE I&ILaurence Lambert-Côté, Annie Turgeon, Kristina M Blackmore, et al.
Pageof 29